Back to results
US 2021/0267961 A1Published application
Method of treating laminopathies
AssigneeEiger BioPharmaceuticals, Inc.
InventorsRichard Anthony Franco, JR., Colin Michael Hislop
Life of this patent
Estimating the term…
Abstract
Methods of treating progeria, including HGPS and PL, are provided. In some embodiments, the method comprises administering to a subject having progeria a formulation of lonafarnib.
Claims12
A method of treating a subject with laminopathies comprising:
- administering 150 mg/m2 rounded to the nearest 25 mg/m2 of lonafarnib to a subject, wherein sensitive substrates of CYP3A are contraindicated in subjects being administered lonafarnib.
Dependencies are inferred from the claim text.